KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Non-Current Debt (2016 - 2026)

Zimmer Biomet Holdings has reported Non-Current Debt over the past 18 years, most recently at $6.3 billion for Q1 2026.

  • For Q1 2026, Non-Current Debt fell 4.28% year-over-year to $6.3 billion; the TTM value through Mar 2026 reached $6.3 billion, down 4.28%, while the annual FY2025 figure was $6.9 billion, 29.77% up from the prior year.
  • Non-Current Debt for Q1 2026 was $6.3 billion at Zimmer Biomet Holdings, down from $6.9 billion in the prior quarter.
  • Over five years, Non-Current Debt peaked at $7.5 billion in Q3 2025 and troughed at $4.0 billion in Q2 2024.
  • A 5-year average of $5.5 billion and a median of $5.2 billion in 2023 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: dropped 29.88% in 2022 and later surged 70.66% in 2025.
  • Year by year, Non-Current Debt stood at $5.2 billion in 2022, then fell by 5.52% to $4.9 billion in 2023, then rose by 9.73% to $5.3 billion in 2024, then grew by 29.77% to $6.9 billion in 2025, then decreased by 9.19% to $6.3 billion in 2026.
  • Business Quant data shows Non-Current Debt for ZBH at $6.3 billion in Q1 2026, $6.9 billion in Q4 2025, and $7.5 billion in Q3 2025.